MONITORING PRESCRIPTIONS
Local prescribers are registering and utilizing the CURES 2.0 (Controlled Substance Utilization Review and Evaluation System) at increasing rates. The interactive CURES database provides the highest level of prescription drug monitoring available. It discourages “doctor shopping,” reduces overprescribing, contains information on the prescribing and dispensing of controlled substances, including opioids, and protects patients who require painkiller medication.
“Prescription Drug Monitoring Programs (PDMPs) continue to be among the most promising state-level interventions to improve opioid prescribing, inform clinical practice, and protect patients at risk.”
– Centers for Disease Control & Prevention, 2016
CURES (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, Schedule III, Schedule IV and Schedule V controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement. CURES is committed to the reduction of prescription drug abuse and diversion without affecting legitimate medical practice or patient care.
Updated regulations pertaining to the Controlled Substance Utilization Review and Evaluation System (CURES) became effective on August 15, 2022. The regulations revise and add to the CURES access and use regulations that took effect on July 1, 2020.
Our objective is to encourage and facilitate CURES registration and utilization with local education, on-site training, and promotion.
